InterCure Ltd. (TLV:INCR)
Israel
· Delayed Price · Currency is ILS · Price in ILA 564.30
+12.00 (2.17%)
May 14, 2025, 10:24 AM IDT
InterCure Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 238.85 | 355.55 | 388.68 | 219.68 | 65.04 | Upgrade
|
| Revenue Growth (YoY) | -32.82% | -8.52% | 76.93% | 237.78% | 628.60% | Upgrade
|
| Cost of Revenue | 196.79 | 246.95 | 216.67 | 117.11 | 31.45 | Upgrade
|
| Gross Profit | 42.05 | 108.6 | 172.01 | 102.56 | 33.59 | Upgrade
|
| Selling, General & Admin | 107.89 | 95.88 | 92.62 | 50.42 | 17.03 | Upgrade
|
| Research & Development | 0.41 | 0.39 | 0.63 | 1.24 | 1.58 | Upgrade
|
| Other Operating Expenses | 19.35 | 9.64 | 29.63 | 14.4 | 6.18 | Upgrade
|
| Operating Expenses | 129.94 | 108.5 | 131.78 | 72.51 | 34.79 | Upgrade
|
| Operating Income | -87.89 | 0.11 | 40.23 | 30.05 | -1.21 | Upgrade
|
| Interest Expense | -20.65 | -24.22 | -14.69 | -0.42 | -0.26 | Upgrade
|
| Interest & Investment Income | 2.7 | 5.38 | 0.84 | 0.13 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.02 | -0.05 | 7.33 | -4.54 | 0.6 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.15 | -0.83 | -0.27 | -4.63 | -0.26 | Upgrade
|
| EBT Excluding Unusual Items | -108 | -19.61 | 33.44 | 20.6 | -1.11 | Upgrade
|
| Impairment of Goodwill | - | -63.1 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -12.22 | -3 | -0.17 | -1.87 | -37.2 | Upgrade
|
| Asset Writedown | - | -4.59 | - | - | - | Upgrade
|
| Other Unusual Items | 32.9 | 29.01 | 10.57 | - | - | Upgrade
|
| Pretax Income | -87.32 | -61.29 | 43.84 | 18.73 | -38.31 | Upgrade
|
| Income Tax Expense | -14.53 | 2.25 | 0.09 | 11.44 | -2.27 | Upgrade
|
| Earnings From Continuing Operations | -72.79 | -63.53 | 43.75 | 7.29 | -36.04 | Upgrade
|
| Minority Interest in Earnings | 5 | 1.57 | 1.07 | -2.6 | -1.19 | Upgrade
|
| Net Income | -67.8 | -61.96 | 44.82 | 4.69 | -37.23 | Upgrade
|
| Net Income to Common | -67.8 | -61.96 | 44.82 | 4.69 | -37.23 | Upgrade
|
| Net Income Growth | - | - | 855.63% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 46 | 46 | 45 | 38 | 25 | Upgrade
|
| Shares Outstanding (Diluted) | 46 | 46 | 45 | 41 | 25 | Upgrade
|
| Shares Change (YoY) | 0.65% | 0.48% | 11.05% | 60.81% | 9.00% | Upgrade
|
| EPS (Basic) | -1.48 | -1.36 | 0.99 | 0.12 | -1.47 | Upgrade
|
| EPS (Diluted) | -1.48 | -1.36 | 0.99 | 0.11 | -1.47 | Upgrade
|
| EPS Growth | - | - | 798.39% | - | - | Upgrade
|
| Free Cash Flow | -71.3 | -56.25 | 31.53 | 16.11 | -12.95 | Upgrade
|
| Free Cash Flow Per Share | -1.55 | -1.23 | 0.69 | 0.39 | -0.51 | Upgrade
|
| Gross Margin | 17.61% | 30.54% | 44.26% | 46.69% | 51.65% | Upgrade
|
| Operating Margin | -36.80% | 0.03% | 10.35% | 13.68% | -1.85% | Upgrade
|
| Profit Margin | -28.38% | -17.43% | 11.53% | 2.14% | -57.25% | Upgrade
|
| Free Cash Flow Margin | -29.85% | -15.82% | 8.11% | 7.33% | -19.91% | Upgrade
|
| EBITDA | -78.22 | 8.29 | 51.93 | 37.45 | 2.05 | Upgrade
|
| EBITDA Margin | -32.75% | 2.33% | 13.36% | 17.05% | 3.15% | Upgrade
|
| D&A For EBITDA | 9.67 | 8.18 | 11.7 | 7.39 | 3.25 | Upgrade
|
| EBIT | -87.89 | 0.11 | 40.23 | 30.05 | -1.21 | Upgrade
|
| EBIT Margin | -36.80% | 0.03% | 10.35% | 13.68% | -1.85% | Upgrade
|
| Effective Tax Rate | - | - | 0.21% | 61.07% | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.